• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Attana

0.01 SEK

0.00 %

Less than 1K followers

ATANA

NGM Growth Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
0.00 %
+33.33 %
0.00 %
-11.11 %
-20.00 %
-61.90 %
-89.01 %
-99.00 %
-94.80 %

Attana conducts research and development of pharmaceuticals. The company specializes in biological interaction characterization, which is used for analysis in the development of new drugs. The company's patented solutions are used in the study of binding properties and macrostructures in cells, proteins, viruses and bacteria. Operations are primarily in the Nordic region and Europe. The company was founded in 2002 and is headquartered in Stockholm.

Read more
Market cap
51.61M SEK
Turnover
140.69K SEK
Revenue
2.47M
EBIT %
-429.91 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
3rd party
ShowingAll content types

Forum discussions
Attana has signed a 5-year contract in the USA, which will positively impact cash flow during the contract period. Earlier this year, news broke about a collaboration and research agreement with a US university hospital. Smaller news items have also recently emerged regarding new...
4/25/2022, 1:58 PM
by Mikael Kahn
4
Cut your losses quickly is a pretty good saying for companies like these.
12/9/2023, 12:32 PM
by Warren Noutopöytätarjoilu
1
A share issue is incoming. I’m wondering if I should finally realize these -95% losses or continue to fund this sinking ship. Is anyone else still on board?
12/8/2023, 12:14 PM
by III21
1
News Powered by Cision Attana plans to move production of consumables to AroCell Attana can today announce that the company has begun a discussion about moving production of
5/5/2022, 4:47 PM
by PP2020
1
This multibagger seems to have multibagged in the other direction, meaning only 1/20th of the value is left.
12/9/2023, 11:10 AM
by Tunturisusi
0
Got a small pile souring at the bottom of my portfolio and I’m not really that excited to participate in the offering. I have to admit I haven’t followed the company’s activities at all lately.
12/9/2023, 8:13 AM
by ghoul
0
Börskollen Kvartalsrapport för perioden 1 januari - 31 mars 2022 i Attana AB Pressmeddelande i aktien Attana. Kvartalsrapport för perioden 1 januari - 31 mars 2022 i Attana AB. Financial overview (not audited by the company’s auditor): Net sales SEK 3.1 (1.1) million Other operating...
5/6/2022, 6:11 AM
by Tume
0
Read more on our forum
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
29/8
2026

Interim report Q2'26

29/11
2026

Interim report Q3'26

Press release19 hours ago

Attanas teknik använd i ny vetenskaplig publikation inom cancerdiagnostik

Attana
Regulatory press release6/16/2026, 6:00 AM

Mercodia förlänger hyravtal med Attana och går vidare till nästa fas av projektet

Attana
Regulatory press release6/15/2026, 3:31 PM

Attana meddelar med sorg att styrelseledamoten Rolf Lundh har avlidit efter en tids sjukdom

Attana

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release6/15/2026, 5:44 AM

Attanas piezoelektriska patent beviljas i USA

Attana
Press release6/12/2026, 6:00 AM

Idag inleds teckningsperioden i Attanas företrädesemission

Attana
Press release6/11/2026, 6:00 AM

Attana offentliggör förenklat informationsdokument inför kommande företrädesemission av units

Attana
Press release6/9/2026, 1:53 PM

Attana förtydligar användningsområden och kommersiell potential för bolagets piezoelektriska patent

Attana
Press release6/3/2026, 3:10 PM

Kommuniké från extra bolagsstämma i Attana AB

Attana
Regulatory press release6/1/2026, 7:47 AM

Kvartalsrapport för Attana AB, 556931-4106, perioden 260101-260331

Attana
Press release5/20/2026, 6:16 AM

Attana och Offspring Biosciences presenterar första positiva resultat från pilotstudie i mänsklig bröstcancervävnad

Attana
Regulatory press release5/15/2026, 9:49 AM

Attana: KALLELSE TILL EXTRA BOLAGSSTÄMMA I ATTANA AB (PUBL)

Attana
Regulatory press release5/13/2026, 4:59 PM

Attanas styrelse föreslår företrädesemission om cirka 23,2 MSEK säkerställd till ca 57,9 procent

Attana
Press release5/13/2026, 3:56 PM

Kommuniké från årsstämma 2026 i Attana AB (publ)

Attana
Regulatory press release4/23/2026, 4:07 PM

Attana erhåller indikation på väsentligt värde - ingår avsiktsförklaring om försäljning av piezoelektriskt patent

Attana
Press release4/16/2026, 7:25 AM

Attana installerar instrument hos CRO - inleder pilotstudie inom antikroppsanalys i mänsklig vävnad

Attana
Press release4/10/2026, 2:25 PM

Attana: KALLELSE TILL ÅRSSTÄMMA I ATTANA AB (PUBL)

Attana
Regulatory press release4/10/2026, 2:24 PM

Attana offentliggör preliminärt resultat för första kvartalet 2026 samt avser föreslå minskning av aktiekapitalet för täckning av förlust

Attana
Regulatory press release2/27/2026, 10:30 AM

Bokslutskommuniké för Attana AB för perioden 1 januari-31 december 2025

Attana
Press release2/26/2026, 8:45 AM

Attanas teknik använd i ny publikation i Nature Communications

Attana
Press release2/20/2026, 7:00 AM

Attana och Offspring Biosciences inleder pilotprojekt för att validera antikroppars bindning i mänsklig vävnad

Attana